Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Current Pharmaceutical Design|December 5, 2000
COX-2 and the kidneysD O Stichtenoth, J C Frölich
British Journal of Rheumatology|May 5, 1998
Nitric oxide and inflammatory joint diseasesD O Stichtenoth, J C Frölich
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 1, 1997
Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteersD O Stichtenoth, B Wagner, J C Frölich
Medizinische Klinik (Munich, Germany : 1983)|August 26, 1998
[New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase]D O Stichtenoth, H Zeidler, J C Frölich
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|September 16, 1998
Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteersD O Stichtenoth, B Wagner, J C Frölich
European Journal of Clinical Pharmacology|November 9, 2001
Blood donors on medication. Are deferral periods necessary?D O Stichtenoth, H R Deicher, J C Frölich
European Journal of Clinical Pharmacology|April 17, 2002
Knowledge on drug dosages of ward physiciansJ U Schnurrer, D O Stichtenoth, J C Frölich
Annals of the Rheumatic Diseases|October 1, 1995
Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisoloneD O Stichtenoth, J Fauler, H Zeidler, et al.
British Journal of Clinical Pharmacology|April 25, 2001
Drug expenditure in hospitals: what do German ward physicians know?J U Schnurrer, D O Stichtenoth, R Troost, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in manD O Stichtenoth, D Tsikas, F M Gutzki, et al.
Pageof 21